(Q40939208)

25 September 2017

title

Selective down-regulation of T cell- and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone (English)

1 reference

25 September 2017

0 references

0 references

1 reference

Rowland TL

1

1 reference

25 September 2017

McHugh SM

2

1 reference

25 September 2017

Deighton J

3

1 reference

25 September 2017

Ewan PW

4

1 reference

25 September 2017

Dearman RJ

5

1 reference

25 September 2017

Kimber I

6

1 reference

25 September 2017

publication date

1 June 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

68

1 reference

25 September 2017

issue

2-3

1 reference

25 September 2017

page(s)

325-332

1 reference

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide inhibits the replication of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

New roles for thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide prolonged graft survival in a rat cardiac transplant model but had no inhibitory effect on lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide protects mice against LPS-induced shock

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Molecular actions of glucocorticoids: an introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

The transmembrane orientation of the epsilon chain of the TcR/CD3 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Structural features and biochemical properties of TNF-alpha converting enzyme (TACE).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Structures of adamalysin II with peptidic inhibitors. Implications for the design of tumor necrosis factor alpha convertase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900055-3

7 January 2021

10.1016/S0165-2478(99)00055-3

Identifiers

DOI

1 reference

25 September 2017

1 reference